Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 90

Sort by

Sort Order Select

Journal Articles

Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma

Tanaya Shree, MDPhDBA, Michael S. Khodadoust, MD PhD, Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Sara Beygi, MD, Steven R. Long, MD, Brock Martin, MD, Ronald Levy, MD

Blood (2020) 136 (Supplement 1): 48.

https://doi.org/10.1182/blood-2020-141377

Published: 2020

Journal Articles

Single Cell Analysis of Serial Lymphoma Biopsies Reveals Dynamic Immune Modulation and Predictors of Response in Patients Undergoing in Situ Vaccination

Tanaya Shree, MDPhDBA, Sarah Haebe, MD, Anuja Sathe, PhD, Grady Day, Debra K. Czerwinski, BA, HoJoon Lee, PhD, Susan Grimes, BSc, Steven R. Long, MD, Brock Martin, MD, Hanlee Ji, MD, Ronald Levy, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-141672

Published: 2020

Journal Articles

Site to Site Comparison of Follicular Lymphoma Biopsies By Single Cell RNA Sequencing

Sarah Haebe, MD, Tanaya Shree, MDPhDBA, Anuja Sathe, PhD, Grady Day, HoJoon Lee, PhD, Debra K. Czerwinski, BA, Susan Grimes, BSc, Hanlee Ji, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 297.

https://doi.org/10.1182/blood-2019-129445

Published: 2019

Journal Articles

Maria-I: A Deep-Learning Approach for Accurate Prediction of MHC Class I Tumor Neoantigen Presentation

Karan R. Kathuria, Binbin Chen, PhD, Michael S. Khodadoust, MD PhD, Niclas Olsson, PhD, Mark M Davis, PhD, Joshua E Elias, PhD, Ronald Levy, MD, Russ B. Altman, MD PhD, Arash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 84.

https://doi.org/10.1182/blood-2019-129334

Published: 2019

Journal Articles

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Tanaya Shree, MD PhD, Michael S. Khodadoust, MD PhD, Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Wan X. Hong, MD, Rachel Greenstein, Steven R. Long, MD, Brock Martin, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 2825.

https://doi.org/10.1182/blood-2019-129661

Published: 2019

Journal Articles

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Tanaya Shree, MD PhD, Sarah Haebe, MD, Anuja Sathe, PhD, Grady Day, HoJoon Lee, PhD, Debra K. Czerwinski, BA, Susan Grimes, BSc, Hanlee Ji, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 1479.

https://doi.org/10.1182/blood-2019-131684

Published: 2019

Journal Articles

Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and Non-Injected Tumor Sites in Patients with Low-Grade Lymphoma

Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Tanaya Shree, MD PhD BA, Michael S Khodadoust, MD PhD, Steven R. Long, MD, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 1612.

https://doi.org/10.1182/blood-2018-99-119931

Published: 2018

Journal Articles

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Tanaya Shree, MD PhD BA, Anuja Sathe, PhD, Debra K. Czerwinski, BA, Steven R. Long, MD, Hanlee Ji, MD, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 4107.

https://doi.org/10.1182/blood-2018-99-119925

Published: 2018

Journal Articles

In Situ Vaccination with Cpg and Anti-OX40 Antibody: Preclinical Optimization for Clinical Translation

Idit Sagiv Barfi, PhD, Debra K. Czerwinski, BA, Tanaya Shree, MD PhD BA, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 2943.

https://doi.org/10.1182/blood-2018-99-117872

Published: 2018

Journal Articles

Eradication of Systemic Lymphoma By Local Immunotherapy

Idit Sagiv Barfi, PhD, Debra K. Czerwinski, BA, Ronald Levy, MD

Blood (2017) 130 (Supplement 1): 113.

https://doi.org/10.1182/blood.V130.Suppl_1.113.113

Published: 2017

Journal Articles

Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study

Tanaya Shree, MD PhD, Qian Li, MS, Sally L. Glaser, PhD, Holden T. Maecker, PhD, Robert W. Haile, PhD MPH, Ronald Levy, MD, Theresa H.M. Keegan, PhD MS

Blood (2017) 130 (Supplement 1): 198.

https://doi.org/10.1182/blood.V130.Suppl_1.198.198

Published: 2017

Journal Articles

In-Situ Vaccination Using Sting Agonists Combined with Immune-Modulating Antibodies to Treat Lymphoma

Adrienne Sallets, PhD, Adel Kardosh, Sophie Robinson, BS, Ronald Levy, MD

Blood (2017) 130 (Supplement 1): 4102.

https://doi.org/10.1182/blood.V130.Suppl_1.4102.4102

Published: 2017

Journal Articles

Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 826.

https://doi.org/10.1182/blood.V130.Suppl_1.826.826

Published: 2017

Journal Articles

Altered Peripheral Immune Phenotypes in Mantle Cell Lymphoma Survivors

Tanaya Shree, MD PhD, Sangeeta Kowli, PhD, Holden T. Maecker, PhD, Ronald Levy, MD

Blood (2017) 130 (Supplement 1): 2759.

https://doi.org/10.1182/blood.V130.Suppl_1.2759.2759

Published: 2017

Journal Articles

Maria: Accurate Prediction of MHC-II Peptide Presentation with Deep-Learning and Lymphoma Patient MHC-II Ligandome

Binbin Chen, BS, Michael Khodadoust, MD PhD, Niclas Olsson, PhD, Ethan Fast, BS, Lisa E Wagar, PhD, Chih Long Liu, PhD, Mark Davis, PhD, Ronald Levy, MD, Joshua E Elias, PhD, Russ B Altman, MD PhD, Arash A. Alizadeh, MD PhD

Blood (2017) 130 (Supplement 1): 1486.

https://doi.org/10.1182/blood.V130.Suppl_1.1486.1486

Published: 2017

Journal Articles

Single-Cell Analysis of the Immune Microenvironment in Follicular Lymphoma: Cell Surface Protein Vs. Intracellular mRNA

Debra K. Czerwinski, BA, Ronald Levy, MD

Blood (2017) 130 (Supplement 1): 5144.

https://doi.org/10.1182/blood.V130.Suppl_1.5144.5144

Published: 2017

Journal Articles

Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations

Max Jan, MD PhD, Florian Scherer, MD, David M. Kurtz, MD, Aaron M Newman, PhD, Henning Stehr, PhD, Chih Long Liu, PhD, Li Zhou, Cynthia Glover, Ranjana H Advani, MD, Lauren S Maeda, MD, Neel K. Gupta, MD, Ronald Levy, MD, Christian A. Kunder, MD PhD, Isidro Sánchez-García, MD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2016) 128 (22): 4107.

https://doi.org/10.1182/blood.V128.22.4107.4107

Published: 2016

Journal Articles

Noninvasive Detection of BCL2 , BCL6 , and MYC Translocations in Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 2930.

https://doi.org/10.1182/blood.V128.22.2930.2930

Published: 2016

Journal Articles

DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 2686.

https://doi.org/10.1182/blood.V128.22.2686.2686

Published: 2016

Journal Articles

SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial

Ronald Levy, MD, Patrick M. Reagan, MD, Jonathan W. Friedberg, MD, Nancy L Bartlett, MD, Leo I. Gordon, MD, Abraham Leung, MD, Joanna Peterkin, MD MS, Biao Xing, Robert Coffman, PhD, Robert Janssen, MD, Albert Candia, PhD, Michael Khodadoust, MD PhD, Matthew J. Frank, MD PhD, Steven R Long, MD, Debra K Czerwinski, Michael Chu, MD

Blood (2016) 128 (22): 2974.

https://doi.org/10.1182/blood.V128.22.2974.2974

Published: 2016

NARROW

Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma

Single Cell Analysis of Serial Lymphoma Biopsies Reveals Dynamic Immune Modulation and Predictors of Response in Patients Undergoing in Situ Vaccination

Site to Site Comparison of Follicular Lymphoma Biopsies By Single Cell RNA Sequencing

Maria-I: A Deep-Learning Approach for Accurate Prediction of MHC Class I Tumor Neoantigen Presentation

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and Non-Injected Tumor Sites in Patients with Low-Grade Lymphoma

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

In Situ Vaccination with Cpg and Anti-OX40 Antibody: Preclinical Optimization for Clinical Translation

Eradication of Systemic Lymphoma By Local Immunotherapy

Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study

In-Situ Vaccination Using Sting Agonists Combined with Immune-Modulating Antibodies to Treat Lymphoma

Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma

Altered Peripheral Immune Phenotypes in Mantle Cell Lymphoma Survivors

Maria: Accurate Prediction of MHC-II Peptide Presentation with Deep-Learning and Lymphoma Patient MHC-II Ligandome

Single-Cell Analysis of the Immune Microenvironment in Follicular Lymphoma: Cell Surface Protein Vs. Intracellular mRNA

Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations

Noninvasive Detection of BCL2 , BCL6 , and MYC Translocations in Diffuse Large B-Cell Lymphoma

DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma

SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only